Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Efficacy and Safety of IMVT-1402 in Adult Participants With Primary Sjogren's Disease With Moderate to Severe Systemic Disease ActivityPrimary Sjögren's SyndromeActive, not recruitingPhase 22026-09-10NCT06979531

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Immunovant Sciences GmbH8

96 results · Page 1 of 4

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Site Number - 1000MemphisUnited States1
Site Number - 1001AllenUnited States1
Site Number - 1002MiamiUnited States2
Site Number - 1004TamaracUnited States1
Site Number - 1006MineolaUnited States1
Site Number - 1007El CajonUnited States1
Site Number - 1010HoustonUnited States1
Site Number - 1011HoustonUnited States1
Site Number - 1012ChicagoUnited States1
Site Number - 1013PhiladelphiaUnited States1
Site Number - 1014Fort CollinsUnited States1
Site Number - 1015JacksonUnited States1
Site Number - 1016MenifeeUnited States1
Site Number - 1018HollywoodUnited States1
Site Number - 1019AustinUnited States1
Site Number - 1020AmarilloUnited States1
Site Number - 1021JupiterUnited States1
Site Number - 1022ArlingtonUnited States1
Site Number - 1023KatyUnited States1
Site Number - 1024GrapevineUnited States1
Site Number - 1025TampaUnited States1
Site Number - 1026UplandUnited States1
Site Number - 1027CovinaUnited States1
Site Number - 1028New OrleansUnited States1
Site Number - 1029Thousand OaksUnited States1